{
    "prompt": "\n    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n    {\n        \"Status\": \"no_match\",\n        \"Message\": \"No drugs are FDA-approved for the provided context\"\n    }\n    \n    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n    {\n        \"Status\": \"success\",\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\": \n            \"FDA-approval status\":\n            \"Link to FDA-approved Label\":\n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0002079\nAge: 76\nGender: Male\nSample ID: P-0002079-T01-IM3\nGene Panel: IMPACT341\nCancer Type: Lung Adenocarcinoma\nSample Type: Metastasis\nTumor Purity: 50.0%\n=============\nDNA Variants:\nARID1A c.4606G>C (p.D1536H) - in 16.00% of 1149 reads\nBRCA2 c.6137C>T (p.S2046L) - in 21.00% of 714 reads\nIDH2 c.817C>G (p.H273D) - in 14.00% of 872 reads\nMLL3 c.8137_8139delinsTAA (p.D2713*) - in 35.00% of 1745 reads\nMTOR c.7149G>C (p.L2383F) - in 15.00% of 944 reads\nNOTCH2 c.1076C>T (p.S359F) - in 16.00% of 1120 reads\nSPEN c.6556G>A (p.A2186T) - in 18.00% of 448 reads\nCNA Data:\nNo CNA data found.\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Status\": \"no_match\",\n  \"Message\": \"No drugs are FDA-approved for the provided context\"\n}"
}